Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare. The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry. Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.

Share:
More In Science
Hawaii Sets Its Sights on 100% Renewable Energy
Hawaii aims to be completely reliant on renewable sources of energy by 2045, says Connie Lau, president and CEO of Hawaiian Electric Industries and chairman of Hawaiian Electric Company. To do so, she said the state can use its natural advantages in solar and wind.
Peloton: The Netflix of Fitness?
The stationary bike and treadmill maker is now valued at over $4 billion after its latest funding round. Maureen Farrell, reporter at the Wall Street Journal, tells Cheddar that most companies claim to be the Netflix of their industry, but in Peloton's case, it may actually be true.
Why Wildfires Are Starting in Unusual Places
Wildfires have burned in some unusual places this year, including some of the northernmost countries of Europe, where residents are experiencing severe droughts and record high temperatures. Some scientists say this could be the new normal.
Load More